The impact of disease-drug interactions on drug development and clinical practice

被引：5
|
作者：
Cai, Hualin [1 ,2 ]
Chen, Xia [3 ,4 ]
机构：
[1] Cent South Univ, Dept Pharm, Xiangya Hosp 2, Changsha, Peoples R China
[2] Cent South Univ, Inst Clin Pharm, Changsha, Peoples R China
[3] Capital Med Univ, Beijing Tiantan Hosp, Phase Unit 1, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Tiantan Hosp, Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2021年 / 87卷 / 03期
关键词：
PHARMACOKINETICS;
D O I：
10.1111/bcp.14469
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：712 / 714
页数：3
相关论文
共 50 条
  • [31] BENZODIAZEPINE DRUG-DRUG INTERACTIONS COMMONLY OCCURRING IN CLINICAL-PRACTICE
    ABERNETHY, DR
    GREENBLATT, DJ
    OCHS, HR
    SHADER, RI
    CURRENT MEDICAL RESEARCH AND OPINION, 1984, 8 : 80 - 93
  • [32] PHENYTOIN AND ACENOCOUMAROL: DRUG INTERACTIONS WITH CLINICAL IMPACT
    Carmen, Lopez-Martin
    Daniel, Urdiales
    Vicente, Faus
    ATENCION FARMACEUTICA, 2013, 15 (04): : 299 - 300
  • [33] DRUG-FOOD INTERACTIONS IN CLINICAL-PRACTICE
    YAMREUDEEWONG, W
    HENANN, NE
    FAZIO, A
    LOWER, DL
    CASSIDY, TG
    JOURNAL OF FAMILY PRACTICE, 1995, 40 (04): : 376 - 384
  • [34] CLINICAL ASPECTS OF DRUG ACTIONS AND INTERACTIONS IN VETERINARY PRACTICE
    SZABUNIEWICZ, M
    BAILEY, EM
    WIERSIG, DO
    VETERINARY MEDICINE & SMALL ANIMAL CLINICIAN, 1973, 68 (09): : 1048 - +
  • [35] Factors to consider in managing drug interactions in clinical practice
    Charpiat, Bruno
    Allenet, Benoit
    Roubille, Renaud
    Escofier, Laurence
    Bedouch, Pierrick
    Juste, Michel
    Rose, Francois-Xavier
    Conort, Ornella
    PRESSE MEDICALE, 2008, 37 (04): : 654 - 664
  • [36] NEUROPHARMACOLOGY AND DRUG-INTERACTIONS IN CLINICAL-PRACTICE
    GRAVES, NM
    EPILEPSIA, 1995, 36 : S27 - S33
  • [37] Disease-Drug Interaction of Sarilumab and Simvastatin in Patients with Rheumatoid Arthritis
    Lee, Eun Bong
    Daskalakis, Nikki
    Xu, Christine
    Paccaly, Anne
    Miller, Barry
    Fleischmann, Roy
    Bodrug, Inga
    Kivitz, Alan
    CLINICAL PHARMACOKINETICS, 2017, 56 (06) : 607 - 615
  • [38] DISEASE-DRUG INTERACTION OF SARILUMAB AND SIMVASTATIN IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Lee, E. B.
    Daskalakis, N.
    Xu, C.
    Paccaly, A.
    Miller, B.
    Fleischmann, R.
    Bodrug, I.
    Kivitz, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 960 - 960
  • [39] Impact of drug eluting stents on the clinical practice of revascularisation of coronary artery disease
    de la Torre-Hernandez, Jose M.
    Garcia-Camarero, Tamara
    Burgos-Palacios, Virginia
    Ruiz-Lera, Marta
    Llano-Cardenal, Miguel
    Exposito, Victor
    Sainz-Laso, Fermin
    Lee, Dae-Hyun
    Figueroa, Alvaro
    Zueco, Javier
    EUROINTERVENTION, 2009, 5 (04) : 460 - 464
  • [40] Implications of pharmacogenomics for drug development and clinical practice
    Ginsburg, GS
    Konstance, RP
    Allsbrook, JS
    Schulman, KA
    ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (20) : 2331 - 2336
12345